Translational Omics Analytics

From complex LC-MS/MS data
to decision-ready
biological insight.

Quantira Analytics supports biotech, pharma, CRO, and academic teams with advanced omics data analysis, robust biostatistics, biomarker strategy, and publication-ready scientific reporting.

10+ yrsomics and biomarker experience
LC-MS/MSOrbitrap · QTOF · Triple Quad aware
R-basedreproducible statistical workflows
Proteomics Metabolomics Glycomics Biostatistics Biomarker Strategy
Biotech Pharma R&D CRO Support Clinical Research Academic Labs
Scientific Credibility

Built for teams that need defensible biological claims.

Quantira connects experimental mass spectrometry awareness with statistical discipline and translational biomarker thinking — the combination needed when figures may influence manuscripts, partner discussions, or validation decisions.

Experiment-aware interpretationProteomics, metabolomics, glycomics, targeted LC-MS/MS, DIA/DDA, and clinical metadata are interpreted with assay context in mind.
Statistics that survive reviewClear assumptions, multiple-testing control, robust modeling options, and transparent limitations.
Outputs for real decisionsShortlists, evidence matrices, figure packages, and written interpretation designed for scientific stakeholders.
Solutions

A specialist analytics partner for
high-dimensional biological data.

We combine mass spectrometry knowledge, statistical modeling, and translational interpretation — so your analysis moves beyond p-values into actionable scientific evidence.

🧬
Discovery analytics

Omics Data Analysis

End-to-end analysis of proteomics, metabolomics, glycomics, and targeted LC-MS/MS datasets.

  • Data cleaning and preprocessing
  • Normalization and batch assessment
  • Differential abundance analysis
  • Volcano plots, heatmaps, PCA, clustering
  • Biological interpretation and reporting
📊
Statistical rigor

Biostatistics & Robust Modeling

Statistical workflows designed for noisy, high-dimensional, small-sample, or outlier-prone datasets.

  • Linear and robust regression
  • Multiple testing and FDR control
  • Simulation-based performance evaluation
  • Power, Type I error, bias, MSE, coverage
  • Reproducible R analysis pipelines
🎯
Translational impact

Biomarker Strategy

From candidate discovery to validation planning — prioritizing signals that support real decisions.

  • Biomarker candidate ranking
  • Assay-readiness assessment
  • Study design review
  • Clinical translation logic
  • Decision-oriented evidence summaries
Capabilities

Scientific depth
meets clean execution.

Many analytics providers generate plots. Fewer understand the experimental context, LC-MS/MS constraints, statistical assumptions, and how to frame a defensible biological claim. Quantira is built for that bridge.

Discuss your project →
01

Mass spectrometry-aware analysis

Interpretation informed by Orbitrap, QTOF, Triple Quad, DIA/DDA, targeted workflows, and LC-MS/MS data behavior.

02

Reproducible statistical pipelines

R-based scripts, structured outputs, QC checks, and transparent reporting for reusable, auditable analysis.

03

Publication-ready deliverables

Figures, result tables, methods text, interpretation paragraphs, and reviewer-style methodological justification.

04

Strategic biomarker thinking

Not just "what is significant?" — but "what is robust, interpretable, and worth validating next?"

What you receive

Clear deliverables — not just analysis files.

Each project can be structured around practical outputs your team can immediately use for reporting, manuscripts, partner discussions, or internal decisions.

Publication-ready figures

Volcano plots, PCA, heatmaps, boxplots, forest plots, QC visuals, and export-ready SVG/PNG formats.

Clean result tables

Excel-ready differential abundance tables, ranked biomarkers, annotations, FDR values, and effect-size summaries.

Reproducible code

Structured R scripts, clear output folders, run metadata, and transparent preprocessing or modeling steps.

Scientific interpretation

Decision-oriented summaries, methods/results text, limitations, and next-step recommendations.

Who we serve

Specialized support for
data-heavy life science teams.

Flexible, expert-level support for organizations generating complex biological data that need stronger statistical interpretation, sharper figures, or external scientific review.

Startup

Biotech Startups

Fast, high-quality analytics support when internal headcount is limited but investor or partner expectations are high.

Enterprise

Pharma R&D

Support for translational biomarker programs, exploratory omics studies, and cross-functional evidence packages.

Service

CROs & Service Labs

Advanced data interpretation, statistical reporting, and client-facing scientific deliverables that differentiate your offer.

Academic

Academic Groups

Analysis and visualization support for manuscripts, grants, dissertations, and collaborative research projects.

Example Case Studies

From raw datasets to
scientific decisions.

Representative project types illustrating scope, methodology, and deliverable format. Results are illustrative — real project outputs are shared under confidentiality.

Clinical omics Biomarker discovery R pipeline

Clinical omics biomarker analysis for disease group comparison

Structured preprocessing, transformation, normalization, PCA, differential abundance analysis, and visualization for patient-derived metabolomics or proteomics datasets.

  • QC-driven preprocessing across omics platforms
  • Volcano plots, effect-size interpretation, and biomarker ranking
  • Publication-ready tables, figures, and biological interpretation
Clearer biomarker shortlist and manuscript-ready evidence
Simulation Robust statistics Biostatistics

Simulation study comparing regression methods under contamination

Designed and implemented a simulation framework to compare OLS and robust regression under outliers, sample-size changes, and signal-strength scenarios.

  • Type I error and power estimation
  • Bias, variance, MSE, and coverage
  • Monte Carlo uncertainty assessment
Evidence-based method selection for noisy omics data
Glycomics LC-MS/MS Visualization

Glycan LC-MS/MS interpretation and reporting workflow

Custom workflow connecting chromatographic signals, MS/MS fragments, annotation tables, and publication-style visualizations for glycan characterization.

  • FLD and MS signal integration
  • Fragment spectrum visualization
  • Excel and figure report generation
Interpretable glycan evidence package for reporting
Workflow

A clear process from first discussion
to final deliverables.

01

Scientific Scoping

Define the biological question, dataset structure, comparison groups, assumptions, and success criteria.

02

Data Review

Inspect data files, metadata, missingness, batch structure, assay characteristics, and potential limitations.

03

Analysis Plan

Agree on preprocessing, normalization, statistical models, visualization outputs, and interpretation scope.

04

Execution

Run reproducible scripts, generate QC outputs, figures, tables, and interim interpretation notes.

05

Delivery

Final report, code, figures, result tables, and optional manuscript-ready methods/results text.

"
We do not just analyze omics data. We help scientific teams understand which signals are robust enough to trust, report, and validate.
— Quantira Analytics
LC-MS/MS Experiment-aware analysis and interpretation
R Reproducible statistics and visualization pipelines
FDR Multiple testing strategy and evidence control
QC Quality checks before biological claims
About the Scientist

Senior scientific thinking behind every analysis.

Quantira Analytics is positioned as specialist support for life science teams that need more than routine plotting: experimental context, biostatistical rigor, biomarker logic, and clean scientific communication.

Scientific background: PhD-level omics and biomarker expertise with experience across academic, biotech, and pharmaceutical environments.
Technical depth: LC-MS/MS-aware interpretation across discovery and targeted workflows, including proteomics, metabolomics, and glycomics projects.
Statistical execution: Reproducible R workflows, robust modeling, multiple-testing control, and publication-oriented reporting.
Book an initial discussion →
Start a project

Have omics data that needs stronger analysis?

Send a brief project description and dataset type. We will define the best analytical strategy, expected deliverables, and realistic timeline together.

Free initial 15–20 min project discussion Typical response within 24–48 hours Currently accepting selected new consulting projects
Email: hello@quantira-analytics.com
Location: Germany · Available internationally
Focus: Omics · LC-MS/MS · Biostatistics · Biomarker Strategy
Please answer the human check correctly before sending.